Safety and preliminary antitumor activity of U3-1402: A HER3-targeted antibody drug conjugate in EGFR TKI-resistant, EGFRm NSCLC Meeting Abstract
| Authors: | Janne, P. A.; Yu, H. A.; Johnson, M. L.; Steuer, C. E.; Vigliotti, M.; Iacobucci, C.; Chen, S.; Yu, C.; Sellami, D. B. |
| Abstract Title: | Safety and preliminary antitumor activity of U3-1402: A HER3-targeted antibody drug conjugate in EGFR TKI-resistant, EGFRm NSCLC |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 479s |
| Language: | English |
| ACCESSION: | WOS:000487345806455 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.9010 |
| Notes: | Meeting Abstract: 9010 -- Source: Wos |
